(Press-News.org) A new engineering study has been commissioned by the European Space Agency (under PECS, the Program for European Cooperating States), to prove the reliability of meta-optical elements for space use in a collaboration between the ESA, Bulgarian start-up company LaboraXpert and TMOS, the Australian Research Council Centre of Excellence for Transformative Meta-Optical Systems.
In the first study of its kind, it will determine whether meta-optical components can withstand the pressures of space launch and prolonged exposure to the space environment.
TMOS Centre Director Prof. Dragomir Neshev says, “The demand for Earth observation data is growing, yet the industry still faces the challenge of size and weight constraints when sending a payload into space. Meta-optics will allow for the simultaneous advancement of the functionality and miniaturization of remote sensing systems. This study will provide information towards the development of robust space applications using meta-material optical elements.”
LaboraXpert’s CEO, Dr. Vesselin Vassilev, says, “Space is a booming industry that relies on developing advanced technologies and solutions in various domains. It offers a great opportunity to demonstrate the performance of the advanced imaging systems our company is developing. TMOS’s research goals align closely with our company’s determination to provide ground breaking multi-spectral sensors for space and other applications. We hope this is the first step of a longer term applied R&D collaboration.”
Prof. Neshev says, “We believe meta-optics will enable a new set of innovative applications because of its ability to miniaturise complex optical devices and provide additional embedded functionality of optical systems. Meta-optics significantly outperforms bulky traditional optics in its low size, weight and power requirements, which will have a great benefit for the space industry. Space environment applications are tough ones to succeed in. This project with LaboraXpert and ESA is an indication of the quality cutting-edge technology TMOS is pioneering.”
Both Prof.Neshev and Dr. Vassilev hope this project foreshadows a deepening of advanced industry and research collaboration between Europe and Australia.
For more information about this project, please contact connect@tmos.org.au
END
New deal inked to space test meta-optical surfaces
European Space Agency funds project
2023-05-15
ELSE PRESS RELEASES FROM THIS DATE:
Scientists create first humanised mouse model for rare genetic disease
2023-05-15
Mice with a defected human gene responsible for a rare genetic disease, called congenital adrenal hyperplasia, have been developed for the first time. The achievement, presented at the 25th European Congress of Endocrinology, may help to develop new therapies for people with the most common type of congenital adrenal hyperplasia.
Congenital adrenal hyperplasia (CAH) is a group of inherited conditions, which affects about 1 in 15,000 births. In the most common form, called 21-hydroxylase deficiency, mutations in the CYP21A2 gene cause the adrenal glands ...
Novel sustainable electrochemical method converts carbon dioxide into carbonaceous materials
2023-05-15
Carbon dioxide (CO2) is a major greenhouse gas emitted through various types of human activities. In an effort to decrease humanity’s carbon footprint, scientists and policymakers across the globe are continuously trying to explore new methods for reducing atmospheric CO2 emissions and converting them into useful forms. In this regard, the electrochemical method of reducing CO2 to other carbonaceous forms like carbon monoxide, alcohols and hydrocarbon has gained considerable attention.
Against this ...
Managing menopause: Hormone therapy is back
2023-05-15
Hot flashes, night sweats and sleep disturbances are common symptoms of menopause that can affect health, quality of life and work productivity. A new review published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.221438 recommends menopausal hormone therapy, historically known as hormone replacement therapy (HRT), as first-line treatment in people without risk factors.
Menopausal symptoms may occur up to 10 years before the last menstrual period and can last more than 10 years, with negative effects for many people.
"Menopause and perimenopause can be associated with distressing ...
Can’t find your phone? There’s a robot for that
2023-05-15
Engineers at the University of Waterloo have discovered a new way to program robots to help people with dementia locate medicine, glasses, phones and other objects they need but have lost.
And while the initial focus is on assisting a specific group of people, the technology could someday be used by anyone who has searched high and low for something they’ve misplaced.
“The long-term impact of this is really exciting,” said Dr. Ali Ayub, a post-doctoral fellow in electrical and computer engineering. “A user can be involved not just with a companion robot but a personalized ...
Study shows how both metabolically healthy and unhealthy ‘forms’ of obesity increase risk of various obesity-related cancers
2023-05-14
**Note: the release below is a special early release from the European Congress on Obesity (ECO, Dublin, 17-20 May). Please credit the conference if you use this story**
New research to be presented at this coming week’s European Congress on Obesity in Dublin, Ireland (17-20 May) and published in the Journal of the National Cancer Institute shows that both the metabolically healthy and unhealthy ‘forms’ of obesity are associated with an increased risk of various obesity-related cancers, with the relationship stronger in metabolically unhealthy obesity. The study is by Dr Ming Sun, Lund University, Malmö, ...
Clinically relevant deficiency of the “bonding hormone” oxytocin demonstrated
2023-05-14
The hormone oxytocin is important for social interaction and to control emotions. A deficiency of this hormone has previously been assumed in various diseases such as autism, but has never been proven. Now, for the first time, researchers from the University of Basel and the University Hospital of Basel have succeeded in demonstrating a deficiency of oxytocin in patients with a deficiency of vasopressin caused by a disease of the pituitary gland. This finding could be key to developing new therapeutic approaches.
The hormones oxytocin and vasopressin are produced in the same area of the brain ...
Addiction scientists seek to better understand cocaine use disorder: ‘Stimulants are coming back’
2023-05-14
Nearly 2 percent of the U.S. population reported cocaine use in 2020, and the highly addictive substance was involved in nearly one in five overdose deaths, according to the Centers for Disease Control.
In Virginia, the number of cocaine-related overdoses has been increasing since 2013, with 968 fatal overdoses in 2022, according to preliminary data from the Virginia Department of Health, a 20 percent increase over 2021. Of those, four in five included fentanyl — prescription, illicit or analog — a driving force behind the fatalities.
Researchers at the ...
University of Kentucky physicians push for standard-of-care opioid treatment for incarcerated patients
2023-05-13
In a recently published commentary, UK HealthCare physicians call for standard-of-care treatment for opioid use disorder (OUD) among patients who are incarcerated.
The viewpoint article by Anna-Maria South, M.D., Laura Fanucchi, M.D., and Michelle Lofwall, M.D., published in JAMA April 24 highlights the barriers to initiating medication for opioid use disorder (MOUD) among people who are incarcerated.
For patients with opioid use disorder, medications such as buprenorphine and methadone are considered by the medical community as standard of care treatments, as they alleviate withdrawal symptoms, reduce cravings and pain, ...
Fear of childbirth exacerbated by the COVID-19 pandemic
2023-05-13
The COVID-19 pandemic exacerbated fear of childbirth among pregnant people in the U.S., according to a new Dartmouth study.
The researchers were particularly interested in understanding, from a U.S. context, which factors predict childbirth fear and how the pandemic has affected this fear and birth outcomes. The findings are published in Evolution, Medicine, and Public Health.
"Our results showed really high rates of childbirth fear in our sample," says first author Zaneta Thayer '08, an associate professor of anthropology at Dartmouth. "Since there's no pre-pandemic U.S. data, we cannot compare our data to that context but we know that ...
Restoring control to a particular brain region may help to prevent return to use of opioids
2023-05-13
A team of neuroscientists at the Medical University of South Carolina (MUSC) has identified changes in the activity of brain cells known as pyramidal neurons, which contribute to drug seeking in a preclinical model of opioid use disorder. After access to heroin was stopped, these neurons became more excitable. The activity of these neurons was restored to normal by blocking the enzyme protein kinase A (PKA). Inhibiting this enzyme also reduced opioid-seeking behavior. Jacqueline McGinty, Ph.D., professor of neuroscience, and Saurabh Kokane, Ph.D., a postdoctoral scholar in McGinty’s laboratory, recently published their team’s findings in the Journal of Neuroscience.
The risk ...
LAST 30 PRESS RELEASES:
Orcas seen killing young great white sharks by flipping them upside-down
ETRI achieves feat of having its technology adopted as Brazil’s broadcasting standard
Agricultural practices play a decisive role in the preservation or degradation of protected areas
Longer distances to family physician has negative effect on access to health care
Caution advised with corporate virtual care partnerships
Keeping pediatrics afloat in a sea of funding cuts
Giant resistivity reduction in thin film a key step towards next-gen electronics for AI
First pregnancy with AI-guided sperm recovery method developed at Columbia
Global study reveals how bacteria shape the health of lakes and reservoirs
Biochar reimagined: Scientists unlock record-breaking strength in wood-derived carbon
Synthesis of seven quebracho indole alkaloids using "antenna ligands" in 7-10 steps, including three first-ever asymmetric syntheses
BioOne and Max Planck Society sign 3-year agreement to include subscribe to open pilot
How the arts and science can jointly protect nature
Student's unexpected rise as a researcher leads to critical new insights into HPV
Ominous false alarm in the kidney
MSK Research Highlights, October 31, 2025
Lisbon to host world’s largest conference on ecosystem restoration in 2027, led by researcher from the Faculty of Sciences, University of Lisbon
Electrocatalysis with dual functionality – an overview
Scripps Research awarded $6.9 million by NIH to crack the code of lasting HIV vaccine protection
New post-hoc analysis shows patients whose clinicians had access to GeneSight results for depression treatment are more likely to feel better sooner
First transplant in pigs of modified porcine kidneys with human renal organoids
Reinforcement learning and blockchain: new strategies to secure the Internet of Medical Things
Autograph: A higher-accuracy and faster framework for compute-intensive programs
Expansion microscopy helps chart the planktonic universe
Small bat hunts like lions – only better
As Medicaid work requirements loom, U-M study finds links between coverage, better health and higher employment
Manifestations of structural racism and inequities in cardiovascular health across US neighborhoods
Prescribing trends of glucagon-like peptide 1 receptor agonists for type 2 diabetes or obesity
Continuous glucose monitoring frequency and glycemic control in people with type 2 diabetes
Bimodal tactile tomography with bayesian sequential palpation for intracavitary microstructure profiling and segmentation
[Press-News.org] New deal inked to space test meta-optical surfacesEuropean Space Agency funds project





